Business description
QIAGEN N.V., a Netherlands-based holding company, is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Our sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for analysis. Bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. Automation solutions tie these together in seamless and cost-effective workflows. QIAGEN provides solutions to more than 500,000 customers around the world in Molecular Diagnostics (human healthcare) and Life Sciences (academia, pharma R&D and industrial applications, primarily forensics).
Management board & Supervisory board
| CEO |
| Thierry Bernard |
| Management board |
| Roland Sackers, Fernando Beils, Stephany Foster, Antonio Santos, Nitin Sood, Dr. Jonathan Sheldon, Jean-Pascal Viola |
| Supervisory board |
| Lawrence A. Rosen, Dr. Metin Colpan, Dr. Toralf Haag, Elizabeth E. Tallett, Prof. Dr. Elaine Mardis, Prof. Dr. Ross L. Levine, Dr. Eva Pisa, Steve Rusckowski, Bert van Meurs, Eva van Pelt |
Company data
| Name: |
QIAGEN N.V. |
| Address: |
Spoorstraat 50,NL-5911 KJ Venlo |
| Phone: |
+31-77-320-8400 |
| Fax: |
+31-77-320-8409 |
| E-mail: |
qiagen@qiagen.com
|
| Internet: |
www.qiagen.com |
| Industry: |
Biotechnology |
| Sector: |
Biotechnology |
| Sub sector: |
Biotechnology |
| End of financial year: |
31/12 |
| Free Float: |
60.00% |
| IPO date: |
25/09/1997 |
